Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
AstraZeneca
Merck
Mallinckrodt
Colorcon

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Trehalose

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Trehalose?

Trehalose is an investigational drug.

There have been 8 clinical trials for Trehalose. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.

The most common disease conditions in clinical trials are Macular Edema, Acute Coronary Syndrome, and Muscular Dystrophy, Oculopharyngeal. The leading clinical trial sponsors are Bioblast Pharma Ltd., Retina Associates of Florida, P.A., and Stanley Medical Research Institute.

There are two US patents protecting this investigational drug and thirty-eight international patents.

Recent Clinical Trials for Trehalose
TitleSponsorPhase
Inflammation Reduction by TREhalose AdminisTrationMashhad Razavi HospitalPhase 2
Inflammation Reduction by TREhalose AdminisTrationNational Institute for Medical Research DevelopmentPhase 2
Inflammation Reduction by TREhalose AdminisTrationMashhad University of Medical SciencesPhase 2

See all Trehalose clinical trials

Clinical Trial Summary for Trehalose

Top disease conditions for Trehalose
Top clinical trial sponsors for Trehalose

See all Trehalose clinical trials

US Patents for Trehalose

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Trehalose   Start Trial Compositions and methods for treating Dengue virus infection The J. David Gladstone Institutes (San Francisco, CA) The Regents of the University of California (Oakland, CA)   Start Trial
Trehalose   Start Trial Method of reducing blood glucose by administering RON agonists GENENTECH, INC. (South San Francisco, CA)   Start Trial
Trehalose   Start Trial Expression cassettes derived from maize Syngenta Participations AG (Basel, CH)   Start Trial
Trehalose   Start Trial Soluble mediator The Walter and Eliza Hall Institute of Medical Research (Parkville, AU)   Start Trial
Trehalose   Start Trial Method of preparing carboxylic acid functionalized polymers NEKTAR THERAPEUTICS (San Francisco, CA)   Start Trial
Trehalose   Start Trial Two-phase composition comprising a fatty acid ester of sugar or a liquid alkyl polyglucoside, with an HLB < 8, and a C.sub.8-C.sub.18 branched alkane L'OREAL (Paris, FR)   Start Trial
Trehalose   Start Trial Substituted pyridazines for the treatment of pain INHIBITAXIN LIMITED (Sandwich Kent, GB)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Trehalose

Drugname Country Document Number Estimated Expiration Related US Patent
Trehalose European Patent Office 3166637 2034-07-10   Start Trial
Trehalose World Intellectual Property Organization (WIPO) 2016007540 2034-07-10   Start Trial
Trehalose Brazil 112015012649 2032-11-30   Start Trial
Trehalose Canada 2890305 2032-11-30   Start Trial
Trehalose China 104822706 2032-11-30   Start Trial
Trehalose European Patent Office 2925781 2032-11-30   Start Trial
Trehalose Hong Kong 1212998 2032-11-30   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Dow
Harvard Business School
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.